Cargando…
Boosting Antitumor Immunity with an Expanded Neoepitope Landscape
Immune-checkpoint blockade therapy has been successfully applied to many cancers, particularly tumors that harbor a high mutational burden and consequently express a high abundance of neoantigens. However, novel approaches are needed to improve the efficacy of immunotherapy for treating tumors that...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574376/ https://www.ncbi.nlm.nih.gov/pubmed/35904353 http://dx.doi.org/10.1158/0008-5472.CAN-22-1525 |